Información del producto
Nombre:
Mavacoxib
Sinónimos:
- 4-(5-(4-Fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
- Benzenesulfonamide, 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-
- Mavacoxib [USAN]
- Pha 739,521
- Trocoxil
- Unii-Yft7X7Sr77
Descripción:
Mavacoxib is a nonsteroidal anti-inflammatory drug that inhibits the synthesis of prostaglandins. It has been shown to be effective in the treatment of pain, inflammation, and fever. Mavacoxib has been studied for its potential use as an anticancer agent. In vitro studies have demonstrated that mavacoxib inhibits the growth of cancer cells and induces apoptosis at concentrations below those required for inhibition of cyclooxygenase. The mechanism of action is not fully understood but may involve inhibition of DNA synthesis and cell cycle progression. Mavacoxib has shown antimicrobial resistance in some bacterial strains due to its inability to bind to the active site on bacterial enzymes.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
385.34 g/mol
Fórmula:
C16H11F4N3O2S
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
